World's Best Scientists 2026 revealed!
Jennifer A. Chan

Jennifer A. Chan

D-Index & Metrics

Medicine

D-Index
92
Citations
35257
World Ranking
11206
National Ranking
450

Overview

Jennifer A. Chan is affiliated with the University of Calgary in Canada. Their research spans multiple areas primarily within medicine and biochemistry, genetics, and molecular biology.

The main fields of study for Jennifer A. Chan include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Their work extends into subfields such as:

  • Molecular Biology
  • Oncology
  • Cancer Research
  • Genetics
  • Immunology

The research topics addressed by Jennifer A. Chan cover a range of specialized areas:

  • Glioma Diagnosis and Treatment
  • Cancer Genomics and Diagnostics
  • Single-cell and spatial transcriptomics
  • Neuroblastoma Research and Treatments
  • Neuroendocrine Tumor Research Advances
  • Epigenetics and DNA Methylation
  • Pancreatic and Hepatic Oncology Research

Jennifer A. Chan has contributed to multiple recent papers including the following:

  • Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors, 2024, New England Journal of Medicine
  • Single-cell spatial immune landscapes of primary and metastatic brain tumours, 2023, Nature
  • Failure of human rhombic lip differentiation underlies medulloblastoma formation, 2022, Nature
  • Single-cell landscapes of primary glioblastomas and matched explants and cell lines show variable retention of inter- and intratumor heterogeneity, 2022, Cancer Cell
  • Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression, 2020, Nature Communications

The venues where Jennifer A. Chan frequently publishes include:

  • Cancer Research
  • Neuro-Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • OPAL (Open@LaTrobe) (La Trobe University)

The scientist often collaborates with several researchers, such as:

  • Donna L. Senger
  • A. Sorana Morrissy
  • Jason N. Berman
  • Jeffrey A. Meyerhardt
  • David Malkin

Best Publications

  • MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.

    Jennifer A. Chan;Anna M. Krichevsky;Kenneth S. Kosik

  • Gene regulation and DNA damage in the ageing human brain.

    Tao Lu;Ying Pan;Shyan Yuan Kao;Cheng Li

  • Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma

    Yujin Hoshida;Augusto Villanueva;Masahiro Kobayashi;Judit Peix

  • Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma.

    Yujin Hoshida;Sebastian M.B. Nijman;Sebastian M.B. Nijman;Masahiro Kobayashi;Jennifer A. Chan;Jennifer A. Chan

  • Intertumoral Heterogeneity within Medulloblastoma Subgroups

    Florence M.G. Cavalli;Marc Remke;Marc Remke;Marc Remke;Ladislav Rampasek;John Peacock

  • Physical Activity and Survival After Colorectal Cancer Diagnosis

    Jeffrey A. Meyerhardt;Edward L. Giovannucci;Michelle D. Holmes;Andrew T. Chan

  • Subgroup-specific structural variation across 1,000 medulloblastoma genomes

    Paul A. Northcott;Paul A. Northcott;David J.H. Shih;John Peacock;Livia Garzia

  • CDK8 is a colorectal cancer oncogene that regulates β-catenin activity

    Ron Firestein;Adam Bass;So Young Kim;Ian Frederick Dunn

  • The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer.

    Mark M. Pomerantz;Nasim Ahmadiyeh;Nasim Ahmadiyeh;Li Jia;Paula Herman

  • A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors

    Joshua B. Rubin;Andrew L. Kung;Robyn S. Klein;Jennifer A. Chan

  • Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations

    Pawel Buczkowicz;Christine Hoeman;Patricia Rakopoulos;Sanja Pajovic

  • Consensus guidelines for the management and treatment of neuroendocrine tumors.

    Pamela L. Kunz;Diane Reidy-Lagunes;Lowell B. Anthony;Erin M. Bertino

  • Profiling Critical Cancer Gene Mutations in Clinical Tumor Samples

    Laura E. MacConaill;Catarina D. Campbell;Sarah M. Kehoe;Adam J. Bass

  • Phase II and Pharmacodynamic Study of Autophagy Inhibition Using Hydroxychloroquine in Patients With Metastatic Pancreatic Adenocarcinoma

    Brian M. Wolpin;Douglas A. Rubinson;Xiaoxu Wang;Jennifer A. Chan

  • Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway

    Núria De La Iglesia;Genevieve Konopka;Sidharth V. Puram;Jennifer A. Chan

  • Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study

    Andrew X Zhu;Jeffrey A Meyerhardt;Lawrence S Blaszkowsky;Avinash R Kambadakone

  • Neuroendocrine and adrenal tumors, version 2.2021

    Manisha H. Shah;Whitney S. Goldner;Al B. Benson;Emily Bergsland

  • Childhood cerebellar tumours mirror conserved fetal transcriptional programs

    Maria C. Vladoiu;Ibrahim El-Hamamy;Ibrahim El-Hamamy;Laura K. Donovan;Hamza Farooq

  • Oral mTOR Inhibitor Everolimus in Patients With Gemcitabine-Refractory Metastatic Pancreatic Cancer

    Brian M. Wolpin;Aram F. Hezel;Thomas Abrams;Lawrence S. Blaszkowsky

  • The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors.

    Jonathan R. Strosberg;Thorvardur R. Halfdanarson;Andrew M. Bellizzi;Jennifer A. Chan

Frequent Co-Authors

Matthew H. Kulke
Matthew H. Kulke Boston Medical Center
Jeffrey A. Meyerhardt
Jeffrey A. Meyerhardt Harvard University
Michael D. Taylor
Michael D. Taylor University of Toronto
Cynthia Hawkins
Cynthia Hawkins University of Toronto
Vijay Ramaswamy
Vijay Ramaswamy University of Toronto
Stefan M. Pfister
Stefan M. Pfister German Cancer Research Center
Marco A. Marra
Marco A. Marra University of British Columbia
Eric Bouffet
Eric Bouffet University of Toronto
Nada Jabado
Nada Jabado McGill University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Medicine opens the door to several related fields and online degree options. Beyond the traditional MD or DO pathway, there is a growing demand for professionals in healthcare leadership, advanced practice, and pharmacy careers.

For those interested in healthcare management, online degrees offer flexibility and affordability. You can explore the cheapest mha programs online as well as options tailored specifically for healthcare settings, highlighted in this list of cheapest mha programs online healthcare.

If your passion lies in advanced nursing, consider Doctor of Nursing Practice (DNP) programs designed for working professionals. Find top-quality, affordable options by browsing the cheapest dnp online programs.

Interested in the pharmaceutical industry? Earning a pharmacy doctorate can be more accessible than you think. Review available pharmd online programs to advance your career from anywhere.

These online pathways allow you to specialize in key medical and healthcare roles—often with lower tuition and more flexible schedules—helping you shape a rewarding future in the health sector.

Best Scientists Citing Jennifer A. Chan

Trending Scientists

Recently Published Articles